Federal Register / Vol. 72, No.
92 / Monday, May 14, 2007 / Notices
WYOMING
Albany County
Mountain View Hotel, 2747 WY 130,
Centennial, 07000541
[FR Doc. E7–9171 Filed 5–11–07; 8:45 am]
BILLING CODE 4312–51–P
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 701–TA–409 and 731–
TA–909 (Review)]
Low Enriched Uranium From France
AGENCY: United States International
Trade Commission.
ACTION: Notice of Commission
determinations to conduct full five-year
reviews concerning the antidumping
and countervailing duty orders on low
enriched uranium (‘‘LEU’’) from France.
SUMMARY: The Commission hereby gives
notice that it will proceed with full
reviews pursuant to section 751(c)(5) of
the Tariff Act of 1930 (19 U.S.C.
1675(c)(5)) to determine whether
revocation of the antidumping and
countervailing duty orders on LEU from
France would be likely to lead to
continuation or recurrence of material
injury within a reasonably foreseeable
time. A schedule for the reviews will be
established and announced at a later
date. For further information concerning
the conduct of these reviews and rules
of general application, consult the
Commission’s Rules of Practice and
Procedure, part 201, subparts A through
E (19 CFR part 201), and part 207,
subparts A, D, E, and F (19 CFR part
207).
DATES: Effective Date: April 9, 2007.
FOR FURTHER INFORMATION CONTACT:
Mary Messer (202–205–3193), Office of
Investigations, U.S. International Trade
Commission, 500 E Street, SW.,
Washington, DC 20436. Hearing-
impaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its Internet server (http://
www.usitc.gov). The public record for
these reviews may be viewed on the
pwalker on PROD1PC71 with NOTICES
Commission’s electronic docket (EDIS)
at http://edis.usitc.gov.
SUPPLEMENTARY INFORMATION: On April
9, 2007, the Commission determined
that it should proceed to full reviews in
VerDate Aug<31>2005 18:21 May 11, 2007 Jkt 211001
27151
the subject five-year reviews pursuant to
section 751(c)(5) of the Act.1 The
Commission found that both the
domestic and respondent interested
party group responses to its notice of
institution (72 F.R. 144, January 3, 2007)
were adequate.2 A record of the
Commissioners’ votes, the
Commission’s statement on adequacy,
and any individual Commissioner’s
statements will be available from the
Office of the Secretary and at the
Commission’s Web site.
Authority: These reviews are being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.62 of the
Commission’s rules.
By order of the Commission.
Issued: May 8, 2007.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E7–9148 Filed 5–11–07; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on September 5, 2006,
Noramco Inc., 1440 Olympic Drive,
Athens, Georgia 30601, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule I and II:
Drug
Codeine-N-Oxide (9053) ..............
Morphine-N-Oxide (9307) .............
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Thebaine (9333) ...........................
Opium, raw (9600) .......................
Opium poppy (9650) ....................
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Carfentanil (9743) .........................
Fentanyl (9801) ............................
1 Commissioner Okun did not participate.
2 Commissioner Williamson dissented with
respect to the adequacy of the respondent interested
party group response, finding that the respondent
interested party group response was inadequate.
Commission Williamson also found that other
circumstances warranted conducting full reviews.
PO 00000 Frm 00079 Fmt 4703 Sfmt 4703
The company plans to manufacture
small quantities of the Schedule I
controlled substances for internal
testing; the Schedule II controlled
substances will be manufactured in bulk
for distribution to its customers.
Any other such applicant, and any
person who is presently registered with
the DEA to bulk manufacture such a
substance, may file comments or
objections to the issuance of the
proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than July 13, 2007.
Dated: May 7, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9200 Filed 5–11–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Parole Commission
[(Public Law 94–409) (5 U.S.C. 552b)]
Record of Vote of Meeting Closure
I, Edward F. Reilly, Jr., Chairman of
the United States Parole Commission,
was present at a meeting of said
Schedule
Commission, which started at
I approximately 1:30 p.m., on Thursday,
I April 26, 2007, at the U.S. Parole
II Commission, 5550 Friendship
II
II
Boulevard, 4th Floor, Chevy Chase,
Maryland 20815. The purpose of the
II
meeting was to decide four petitions for
II
II reconsideration pursuant to 28 CFR
II 2.27. Five Commissioners were present,
II constituting a quorum when the vote to
II close the meeting was submitted.
II Public announcement further
II describing the subject matter of the
II meeting and certifications of General
II
II
Counsel that this meeting may be closed
by vote of the Commissioners present
were submitted to the Commissioners
prior to the conduct of any other
business. Upon motion duly made,
seconded, and carried, the following
Commissioners voted that the meeting
be closed: Edward F. Reilly, Jr.,
Cranston J. Mitchell, Deborah A.
E:\FR\FM\14MYN1.SGM 14MYN1